
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
SSE:688505.SS
8.58 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. |
Symbool | 688505.SS |
Munteenheid | CNY |
Prijs | 8.58 |
Beurswaarde | 890,896,192 |
Dividendpercentage | 0.92% |
52-weken bereik | 6.11 - 10.29 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Da Jun Zhao |
Website | https://www.fd-zj.com |
An error occurred while fetching data.
Over Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)